GONO Foundation
@FoundationGono
Followers
267
Following
226
Media
14
Statuses
88
GONO Foundation is a no-profit group of Italian Investigators committed to design & conduct of academic clinical trials in oncology
Joined April 2021
RT @p_ciracimd: Our review and evidence-based algorithm on late-line treatment options for metastatic colorectal cancer patients . 👉 https:….
0
41
0
RT @ArndtVogel: Ramucirumab/paclitaxel as switch maintenance vs continuation of FOLFOX HER2-negative GC/GEJ cancer.@TheLancetOncol .https:/….
0
30
0
RT @JCOPO_ASCO: KRASG12D-Mutated Metastatic #ColorectalCancer: Clinical, Molecular, Immunologic, and Prognostic Features of a New Emerging….
0
4
0
RT @darioT_: The one & only one @Raffa_Casolino 🇺🇳 delivering the Keynote lecture at @AIOMtweet meeting in #Venice right now ! . ✨ An illum….
0
6
0
RT @Erman_Akkus: ☢️Neoadjuvant CRT vs. ChT for initially unresectable locally advanced "Colon" cancer.@eClinicalMed . ➡️45 patients.✅R0 res….
0
79
0
RT @margheambro1: How long should we treat our pts with MSI-H #mCRC with immune checkpoint inhibitors to preserve efficacy while optimizing….
0
7
0
RT @AIOMtweet: Un successo il Congresso Nazionale di AIOM Giovani 2024. Un grande lavoro del Working Group giovani. #AIOM #CongressoNaziona….
0
11
0
RT @margheambro1: Promising combination for mCRC patients not fit for classical 1st line doublet chemo, personally I love this trial by @Fo….
0
1
0
RT @ChiaraCrem1: Updated and OS results of Atezotribe by @FoundationGono 🇮🇹 Confirmed role of IS IC as biomarker of ICI sensitivity in pMMR….
0
10
0
RT @LFerri123: ESOPEC trial.It’s been a long 15 year journey, but so nice to see Docetaxel triplets come on top for the benefit of our pati….
0
19
0
RT @KlempnerSam: Big year for gastroesophageal at #ASCO24 @ASCO .ESOPEC plenary.EA2174, ARMANI, and RENAISSANCE in the oral sessions. @Kar….
0
29
0
RT @ESMO_Open: What are the treatment patterns and outcomes for patients with BRAF-mutant mCRC after progression to encorafenib/cetiximab?….
0
12
0
RT @fedenichetti: Very important data in light of the ongoing PURITY study (NCT06037980) by @Mom_enji and @FoundationGono.
0
7
0
RT @NelsonDusetti: AI-assisted transcriptomic signatures: a key step in personalizing pancreatic cancer treatment. : .
0
2
0
RT @KlempnerSam: Happy to share latest international collaboration led by awesome @arnavmehta3 @AnMinae and others. @JeeyunM @CD_AACR @SU2….
0
11
0
RT @LumishMelissa: Early onset GI cancers will be highlighted at @ASCO #GI24. EO-EGC is rising along with CRC. Our results in @JNCI_Now sho….
0
24
0
RT @DrChoueiri: Paper 2:. Phase 3 trial of KRAS G12C inhibitor #sotorasib + #panitumumab demonstrated ⬆️ PFS in patients with chemo-refract….
0
9
0
RT @Raffa_Casolino: @pradeepbab @SirohiBhawna @SirohiBhawna, I worked with Venkata on a project and he was amazing! He coordinated 41 colle….
0
7
0